|
QIQUM Snapshot - Latest Photos and Galleries
On 15 and 16 October 2010 Kazan, the capital of the Republic of Tatarstan in Russia, hosted the country’s first international conference on medicines entirely independent of the pharmaceutical industry – “Quality Information For Quality Use Of Medicines” – QiQUM-2010. Financial support was provided by the Government of Tatarstan Republic and the following conference co-organizers joined forces:
1. The Eurasian Academy of Medical Sciences,
2. Publishing group GEOTAR-Media,
3. The Institute of Organic and Physical Chemistry, Kazan Scientific Centre, Russian Academy of Sciences,
4. Kazan State Medical Academy,
5. Kazan State Medical University,
6. Kazan State Technological University,
7. Ministry of Health of Tatarstan Republic,
8. Russian Scientific Society of Pharmacologists,
9. Tatneftechim-Invest-Holding,
10. Tatarstan Administration of Roszdravnadzor – Federal Service for Monitoring Healthcare and Social Development.
The Russian Ministry of Health and Social Development endorsed the conference and encouraged participation by health authorities as well as medical and pharmaceutical educators from across the Russian Federation. The conference brought together a total of 414 participants from 9 countries and 20 regions of the Russian Federation. Professor T.V. Yakovleva, Deputy Head of the All-Russian political party “United Russia” sent Governmental greetings from the State Duma to the Conference and its participants, wishing them success in their important mission.
International support and expertise were provided by the invited Conference speakers:
1. Hogerzeil Hans V., MD, PhD, FRCP Edin, DSci – Director, Department of Essential Medicines and Pharmaceutical Policies World Health Organization (Geneva, Switzerland);
2. Burger Edward J., Jr., M.D., Sc.D., FACP – Director, Eurasian Medical Educational Program, Institute for Health Policy Analysis (Washington D.C., USA);
3. Lexchin Joel R., MD – Professor, School of Health Policy and Management at York University; Associate Professor, the Department of Family and Community Medicine, University of Toronto; emergency medicine physician (Toronto, Canada);
4. Mansfield Peter, MD, OAM BMBS – Director of “Healthy Skepticism”, National Institute of Clinical Studies Fellow, and Visiting Research Fellow in the Discipline of General Practice, the University of Adelaide; general practitioner (Adelaide, Australia);
5. Menkes David B., MD, PhD Pharmacology Yale, FRANZCP (Royal Australian and New Zealand College of Psychiatrists), Associate Professor of Psychiatry, Waikato Clinical School, Faculty of Medical and Health Sciences, University of Auckland; consultant liaison psychiatrist (New Zealand);
6. Nirmal Gurbani, Professor and Head of the Pharmacy Department, Public Health Training Institute, S.M.S. Medical College Hospital Campus (India).
The Editor of the International Journal of Risk and Safety in Medicine Professor C.J.Van Boxtel and the publisher IOS Press – Marion Lilley provided a copy of the Journal issue and a flyer to the conference bag (Amsterdam, the Netherlands).
NIS countries (Kazakhstan, Kyrgyzstan and Moldova) and the Russian Federation were represented by academia - Rectors of medical and pharmaceutical higher educational institutions, heads of departments, professors and young scientists; by governmental health care administration and management staff, including the Federal Ministry of Health and Social Development, Roszdravnadzor, Department of Health of Moscow and Moscow district, Centre for sports medicine and anti-doping agency, Ministry of Health of Rostov district, Ministry of Health of the Chuvasch Republic, Ministry of Health of Samara district and Ministry of Health of the Republic of Tatarstan.
Several world leaders in medicine information, pharmaceutical policy and medicine regulation welcomed, endorsed the Conference, and addressed the Conference participants:
Dr. Andrew Herxheimer – clinical pharmacologist, founding Editor of the Drug and Therapeutics Bulletin, consultant and Emeritus fellow of the UK Cochrane Centre, WHO consultant; Extraordinary professor of Clinical Pharmacology at the University of Groningen, Co-convenor of the Cochrane Adverse Effects Methods Group.
Professional Corporation of lawyers Baum, Hedlund, Aristei & Goldman, Washington, D.C. – Los Angeles, California – Philadelphia, PA , USA.
Kees de Joncheere – Regional Adviser, WHO, Regional Office for Europe, Health Technologies and Pharmaceuticals
Barbara Mintzes - Assistant Professor, Department of Anesthesiology, Pharmacology & Therapeutics; Therapeutics Initiative, University of British Columbia, Vancouver B.C., Canada
Sandra van Nuland – project manager, Healthy Skepticism Netherlands.
The Kazan Conference QiQUM 2010 developed as a partner (sister) Conference of the Amsterdam Conference “Selling sickness”, 7-8 October 2010 and the joint WHO/HAI meeting in Moldova on pharmaceutical promotion.
The Founding Editor of the International Journal of Risk and Safety in Medicine Graham.Dukes greeted the Conference participants with his poster which he had prepared for the Amsterdam Conference, presenting “a little history” of the Selling Sickness phenomenon.
Dr. Ken Harvey, Adjunct Senior Lecturer, School of Public Health, La Trobe University presented his poster to Kazan QiQUM Conference with the Australian perspective of the issue and with emphasis on the WHO Ethical Criteria for Medicinal Drug Promotion.
The WHO/HAI collaborative project on drug promotion forwarded the first printed copies of the Russian translation of the Manual “Understanding and responding to pharmaceutical promotion” to the Conference participants.
The key message of the Conference endorsements was, as US Attorneys Baum, Hedlund, Aristei & Goldman put it:
“Western Medicine has strayed from “evidence-based medicine” as a result of being subjected to a massively funded corruption of the medical community so that we now have “spin-based medicine” instead…… Russia has the opportunity to prevent what the West now has to cure.
The related Russian states are at critical cross-roads where they could either be misled into
“spin-based medicine” or, instead, take simple steps to assure reliance on actual “evidence-based medicine,” i.e., a choice between fake science and real science.” (Citation from LEARNING FROM WESTERN MEDICINE’S MISTAKES, October 2010, Statement, made specially for the Kazan Conference QiQUM, Presented by Baum, Hedlund, Aristei & Goldman, Attorneys at Law, available at: http://www.evidenceupdate-tatarstan.ru/conferen/index.php?option=com_content&view=article&id=4&Itemid=9 )
Among priority discussions at the Conference were the following: misleading drug information and how it can be understood; conflicts of interest in modern healthcare; activities of pharmaceutical sales representatives and their impact on health systems.
The idea of the Conference itself and its organization and implementation became possible after the historical statements of the country leadership a year ago – in October 2009, when these issues were identified by the leadership of the Russian Federation – President Dmitry Medvedev and Prime-minister Vladimir Putin -- as priority issues for change.
The most important issues of pharmaceutical policy, access to medicine, medicine regulation and use, were all seen to directly depend on drug information. Accordingly, this information must be of the highest quality and protected from bias in order to promote the scientific basis on which medicine efficacy and safety are assessed. Likewise, such information is vital to assess the proper place of medicines in public health. A key theme of the conference related to the challenges of providing this information to both the health community and the public.
The Conference adopted a Resolution (attached as a separate document), requiring changes from the governmental bodies. The Resolution was sent to the minister of Health and Social Development Tatyana Golikova and to the minister of Education and Science Andrey Fursenko of the Russian Federation and to the interim head of the Federal Service on Surveillance in Healthcare and Social Development Elena Telnova.
Conference materials, including translations of important papers from International participants, were published in a special issue of the Journal “Clinical Pharmacology and Therapeutics” – N 6, 2010, GEOTAR-Media publishing group, Moscow (http://www.geotar.ru/).
The Conference organizers thank all speakers and participants who made the conference happen and ensured its success and beneficial impact on development of health reform in Russia and the NIS countries!
The Conference materials are available at the Conference website: http://evidenceupdate-tatarstan.ru/confer/
The website provides an interface for future communication and collaborative efforts of like-minded people to face the challenges ahead.
Live broadcasting from conference seminars will NOT be available due to technical issues. Thank you for your interest.
15-16 October, 2010
Kazan,
Russain Federation
Welcome message
Dear colleagues,
Five years have passed since the first International conference “Quality Use of Medicines and Pharmacovigilance” was held in Kazan (Resolution of 2005 is here)
Pharmacological, pharmaceutical, epidemiological studies aimed at improving quality of pharmacotherapy and individualization of drug treatment have markedly advanced during this period; the concept of personalized medicine has been formulated.
The concept of delivery of independent comparative information on effects of pharmaceutical interventions in various clinical fields and health systems became ever more important.
Analysis of results of randomized controlled trials and pharmacoepidemiology studies acquires new value and re-thinking is going further and deeper.
Practical utility of these achievements is being broadly discussed from various perspectives, including critical approaches.
New knowledge on misleading pharmaceutical information and on its deleterious effects on prescribing practices has accumulated in global health and in arsenal of medical and pharmaceutical sciences.
The concept of evidence-based medicine – clinical epidemiology has influenced and changed the science and practice of modern health.
The issues of medical and pharmaceutical education and its information basis have become increasingly important.
The search for and development of new approaches and new information technologies to meet the health policy needs of medicine selection for essential medicines lists and standard treatments guidelines is on-going.
New technologies of pharmaceutical knowledge management are urgently needed to be developed and introduced into practice of basic, clinical and pharmaceutical education and in healthcare practice.
The issues of generation of new knowledge on medicines – from the basic research of drug effects, safety and public health value, up to its final presentation to health professionals require priority decisions.
New information technologies, technologies of delivery of independent medicine information to health professionals and general public should become one of mechanisms of new knowledge management.
The issues of new medicine knowledge management for the sake of medicine use for the health and welfare of people will be discussed at the 2nd International conference “Quality information for quality use of medicines”.
We invite you to take active part in this conference.
The organizing committee
|
